Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in a Real-World Setting

被引：0
|
作者：
Bessette, Louis [1 ]
Kapur, Suneil [2 ]
Zummer, Michel [3 ]
Starr, Michael [4 ]
Choquette, Denis [5 ]
Sheriff, Maqbool [6 ]
Olszynski, Wojciech [7 ]
Rampakakis, Emmanouil [8 ]
Psaradellis, Eliofotisti [9 ]
Osborne, Brendan [10 ]
Maslova, Karina [10 ]
Nantel, Francois [10 ]
Lehman, Allen [10 ]
Tkaczyk, Cathy [10 ]
机构：
[1] Ctr Osteoporose & Rhumatol Quebec, Quebec City, PQ, Canada
[2] Univ Ottawa, Ottawa, ON, Canada
[3] Univ Montreal, Dept Med, Montreal, PQ, Canada
[4] McGill, Montreal, PQ, Canada
[5] Inst Rhumatol Montreal, Montreal, PQ, Canada
[6] Nanaimo Reg Hosp, Nanaimo, BC, Canada
[7] Univ Saskatchewan, Saskatoon, SK, Canada
[8] JSS Med Res, Montreal, PQ, Canada
[9] JSS Med Res, St Laurent, PQ, Canada
[10] Janssen Inc, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2016年 / 43卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
119
引用
下载
收藏
页码：1197 / 1197
页数：1
相关论文
共 50 条
  • [41] Clinical and Quality of Life Improvements Observed with Golimumab and Infliximab in a Large Real-Life Ankylosing Spondylitis Population
    van den Bosch, Filip
    Flipo, Rene-Marc
    Braun, Juergen
    Sajjan, Shiva
    Vastesaeger, N.
    Kachroo, Sumesh
    Govoni, Marinella
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [42] SECUKINUMAB EFFECTIVENESS AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY IN THE REAL-WORLD SETTING
    Gaffney, Karl
    Gullick, Nicola
    Kiltz, Uta
    Sfikakis, Petros
    Theodoridou, Athina
    Brandt-Juergens, Jan
    Lespessailles, Eric
    Perella, Chiara
    Pournara, Effie
    Schulz, Barbara
    Veit, Justyna
    RHEUMATOLOGY, 2021, 60 : 99 - +
  • [43] Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting
    Zagni, Emanuela
    Colombo, Delia
    Fiocchi, Martina
    Perrone, Valentina
    Sangiorgi, Diego
    Andretta, Margherita
    De Sarro, Giovambattista
    Nava, Eduardo
    Degli Esposti, Luca
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (05) : 491 - 497
  • [44] INCIDENCE AND DETERMINANTS OF INFECTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH GOLIMUMAB IN REAL-WORLD PRACTICE
    Bessette, L.
    Rahman, P.
    Kelsall, J.
    Purvis, J.
    Rampakakis, E.
    Lehman, A.
    Rachich, M.
    Nantel, F.
    Marrache, M.
    Milan, O. Asin
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1305 - 1305
  • [45] Prevalence of Smoking and Impact on Disease Parameters Among Ankylosing Spondylitis, Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Infliximab or Golimumab in Canada
    Faraawi, Rafat
    Dixit, Sanjay
    Mulgund, Manisha
    Bensen, William
    Kelsall, John
    Choquette, Denis
    Baker, Milton
    Fortin, Isabelle
    Sampalis, John
    Rampakakis, Emmanouil
    Nantel, Francois
    Shawi, May
    Lehman, Allen
    Otawa, Susan
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1330 - 1331
  • [46] EFFICACY AND SAFETY OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS: REAL-WORLD DATA FROM MIDLANDS ANKYLOSING SPONDYLITIS COLLABORATION (MASC)
    Jain, Nibha
    Laxminarayan, Ramasharan
    Moorthy, Arumugam
    Amarasena, Roshan
    Cleaton, Natasha
    Kakade, Girish
    Gunawardane, Aloka
    Khan, Tahir
    Sapkota, Hem
    Barkham, Nick
    RHEUMATOLOGY, 2021, 60
  • [47] The European Ankylosing Spondylitis Infliximab Cohort (EASIC): a European multicentre study of long-term outcomes in patients with ankylosing spondylitis treated with infliximab
    Heldmann, F.
    Brandt, J.
    van der Horst-Bruinsma, I. E.
    Landewe, R.
    Sieper, J.
    Burmester, G. R.
    van den Bosch, F.
    de Vlam, K.
    Geusens, P.
    Gaston, H.
    Schewe, S.
    Appelboom, T.
    Emery, P.
    Dougados, M.
    Leirisalo-Repo, M.
    Breban, M.
    Listing, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 672 - 680
  • [48] Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World Setting
    Seiji Yokoyama
    Yutaka Ishii
    Junya Masuda
    Drugs - Real World Outcomes, 2023, 10 : 51 - 60
  • [49] Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World Setting
    Yokoyama, Seiji
    Ishii, Yutaka
    Masuda, Junya
    DRUGS-REAL WORLD OUTCOMES, 2023, 10 (01) : 51 - 60
  • [50] REAL-WORLD EFFECTIVENESS OF TUMOUR NECROSIS FACTOR INHIBITOR IN ANKYLOSING SPONDYLITIS
    Jones, Gareth T.
    RHEUMATOLOGY, 2017, 56 : 25 - 25
12345